138 related articles for article (PubMed ID: 8027399)
1. Clinical importance of p53 protein in gall bladder carcinoma and its precursor lesions.
Wee A; Teh M; Raju GC
J Clin Pathol; 1994 May; 47(5):453-6. PubMed ID: 8027399
[TBL] [Abstract][Full Text] [Related]
2. [Expression of p53 in gallbladder carcinoma and in dysplastic and metaplastic lesions of the surrounding mucosa].
Billo P; Marchegiani C; Capella C; Sessa F
Pathologica; 2000 Aug; 92(4):249-56. PubMed ID: 11029885
[TBL] [Abstract][Full Text] [Related]
3. p53 immunostaining distinguishes malignant from benign lesions of the gall-bladder.
Oohashi Y; Watanabe H; Ajioka Y; Hatakeyama K
Pathol Int; 1995 Jan; 45(1):58-65. PubMed ID: 7704245
[TBL] [Abstract][Full Text] [Related]
4. p53 and c-erbB-2 protein expression in adenocarcinomas and epithelial dysplasias of the gall bladder.
Kamel D; Pääkkö P; Nuorva K; Vähäkangas K; Soini Y
J Pathol; 1993 May; 170(1):67-72. PubMed ID: 8100854
[TBL] [Abstract][Full Text] [Related]
5. p53 and Ki-67 immunoreactivity and nuclear morphometry of 'carcinoma-in-adenoma' and adenoma of the gall-bladder.
Takei K; Watanabe H; Itoi T; Saito T
Pathol Int; 1996 Nov; 46(11):908-17. PubMed ID: 8970203
[TBL] [Abstract][Full Text] [Related]
6. p53 and Ki-67 immunoreactivity and nuclear morphometry of 'carcinoma-in-adenoma' and adenoma of the gall-bladder.
Takei K; Watanabe H; Itoi T; Saito T
Pathol Int; 1996 Jun; 46(6):426-35. PubMed ID: 8869994
[TBL] [Abstract][Full Text] [Related]
7. Human non-small cell lung cancer: p53 protein accumulation is an early event and persists during metastatic progression.
Fontanini G; Vignati S; Bigini D; Merlo GR; Ribecchini A; Angeletti CA; Basolo F; Pingitore R; Bevilacqua G
J Pathol; 1994 Sep; 174(1):23-31. PubMed ID: 7965400
[TBL] [Abstract][Full Text] [Related]
8. p53 protein expression in sequential biopsies of oral dysplasias and in situ carcinomas.
Regezi JA; Zarbo RJ; Regev E; Pisanty S; Silverman S; Gazit D
J Oral Pathol Med; 1995 Jan; 24(1):18-22. PubMed ID: 7722917
[TBL] [Abstract][Full Text] [Related]
9. Expression of EGF, EGF-receptor, p53, v-erb B and ras p21 in colorectal neoplasms by immunostaining paraffin-embedded tissues.
Hayashi Y; Widjono YW; Ohta K; Hanioka K; Obayashi C; Itoh K; Imai Y; Itoh H
Pathol Int; 1994 Feb; 44(2):124-30. PubMed ID: 7912978
[TBL] [Abstract][Full Text] [Related]
10. p53 protein overexpression in gallbladder carcinoma and its precursor lesions: an immunohistochemical study.
Wistuba II; Gazdar AF; Roa I; Albores-Saavedra J
Hum Pathol; 1996 Apr; 27(4):360-5. PubMed ID: 8617479
[TBL] [Abstract][Full Text] [Related]
11. Expression of MUC1 and MUC2 mucin core proteins and their messenger RNA in gall bladder carcinoma: an immunohistochemical and in situ hybridization study.
Yamato T; Sasaki M; Watanabe Y; Nakanuma Y
J Pathol; 1999 May; 188(1):30-7. PubMed ID: 10398137
[TBL] [Abstract][Full Text] [Related]
12. 'Serrated' adenoma of the colorectum, with reference to its gastric differentiation and its malignant potential.
Yao T; Kouzuki T; Kajiwara M; Matsui N; Oya M; Tsuneyoshi M
J Pathol; 1999 Apr; 187(5):511-7. PubMed ID: 10398114
[TBL] [Abstract][Full Text] [Related]
13. nm23-H1 protein immunoreactivity in cancers of the gallbladder, extrahepatic bile ducts and ampulla of Vater.
Lee CS; Pirdas-Zivcic A
Pathology; 1994 Oct; 26(4):448-52. PubMed ID: 7892048
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemically stained markers (p53, PCNA, bcl-2) in dysplastic lesions of the larynx.
Krecicki T; Jeleń M; Zalesska-Krecicka M; Szkudlarek T; Szajowski K
Cancer Lett; 1999 Aug; 143(1):23-8. PubMed ID: 10465333
[TBL] [Abstract][Full Text] [Related]
15. Intestinal epithelial lesions associated with signet ring cell carcinoma of the colon and small intestine.
Mai KT; Isotalo PA; Guindi M; Burns BF; Parks W
Pathology; 2002 Feb; 34(1):51-6. PubMed ID: 11902446
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical detection of p53 tumor suppressor gene protein in canine epithelial colorectal tumors.
Wolf JC; Ginn PE; Homer B; Fox LE; Kurzman ID
Vet Pathol; 1997 Sep; 34(5):394-404. PubMed ID: 9381650
[TBL] [Abstract][Full Text] [Related]
17. p53 protein immunoreactivity in cancers of the gallbladder, extrahepatic bile ducts and ampulla of Vater.
Lee CS; Pirdas A
Pathology; 1995 Apr; 27(2):117-20. PubMed ID: 7567135
[TBL] [Abstract][Full Text] [Related]
18. Aberrant p53 expression and the development of gallbladder carcinoma and adenoma.
Wang SN; Chung SC; Tsai KB; Chai CY; Chang WT; Kuo KK; Chen JS; Lee KT
Kaohsiung J Med Sci; 2006 Feb; 22(2):53-9. PubMed ID: 16568721
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical analysis of p53 expression in anal squamous neoplasia.
Ogunbiyi OA; Scholefield JH; Smith JH; Polacarz SV; Rogers K; Sharp F
J Clin Pathol; 1993 Jun; 46(6):507-12. PubMed ID: 8392521
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical expression of metallothionein in benign premalignant and malignant epithelium of the larynx: correlation with p53 and proliferative cell nuclear antigen.
Ioachim E; Assimakopoulos D; Peschos D; Zissi A; Skevas A; Agnantis NJ
Pathol Res Pract; 1999; 195(12):809-14. PubMed ID: 10631715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
